STOCK TITAN

Orca Capital reports 9.9% AlphaTON stake (NASDAQ: ATON) filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Orca Capital AG has disclosed a significant passive stake in AlphaTON Capital Corp. The German firm reports beneficial ownership of 1,410,000 Ordinary Shares, representing 9.9% of AlphaTON’s outstanding Ordinary Shares. This percentage is calculated based on 14,314,588 Ordinary Shares outstanding immediately after AlphaTON’s registered offering described in a prospectus filed on January 15, 2026, and excludes 2,340,000 Ordinary Shares issuable upon exercise of pre-funded warrants.

The pre-funded warrants are subject to a 4.99% beneficial ownership blocker, meaning Orca Capital cannot exercise them if doing so would push its beneficial ownership above 4.99% of AlphaTON’s outstanding Ordinary Shares. Orca Capital reports sole voting and dispositive power over the 1,410,000 shares and certifies that the securities are not held for the purpose of changing or influencing control of AlphaTON.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: All ownership percentages set forth in this Schedule 13G are calculated based upon an aggregate of 14,314,588 Ordinary Shares outstanding immediately after giving effect to the completion of the Issuer's registered offering as provided in the Issuer's Prospectus filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on January 15, 2026 and excludes 2,340,000 Ordinary Shares issuable upon the exercise of pre-funded warrants, subject to the 4.99% blocker (defined below). Pursuant to the terms of the pre-funded warrants, the Reporting Person cannot exercise any of the pre-funded warrants to the extent the Reporting Person would beneficially own, after any such exercise, more than 4.99% of the Issuer's outstanding Ordinary Shares (the "4.99% Blocker").


SCHEDULE 13G



Orca Capital AG
Signature:/s/ Thomas Konig
Name/Title:Thomas Konig/Director
Date:01/16/2026

FAQ

What stake does Orca Capital AG report in AlphaTON (ATON)?

Orca Capital AG reports beneficial ownership of 1,410,000 Ordinary Shares of AlphaTON Capital Corp, representing 9.9% of the outstanding class.

How is Orca Capital AG’s 9.9% ownership in AlphaTON calculated?

The 9.9% figure is based on 14,314,588 Ordinary Shares outstanding immediately after AlphaTON’s registered offering described in its Rule 424(b)(5) prospectus filed on January 15, 2026.

What voting and dispositive powers does Orca Capital AG have over AlphaTON shares?

Orca Capital AG reports sole voting power and sole dispositive power over 1,410,000 Ordinary Shares, with no shared voting or dispositive power.

What is the 4.99% blocker mentioned in Orca Capital AG’s AlphaTON filing?

Under the terms of AlphaTON’s pre-funded warrants, Orca Capital AG cannot exercise any warrants to the extent it would then beneficially own more than 4.99% of AlphaTON’s outstanding Ordinary Shares, referred to as the “4.99% Blocker”.

Does Orca Capital AG intend to influence control of AlphaTON Capital Corp?

The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of AlphaTON, and are not held in connection with any transaction having that purpose or effect.

Who signed the Schedule 13G for Orca Capital AG regarding AlphaTON?

The Schedule 13G is signed by Thomas Konig, identified as a Director of Orca Capital AG, dated January 16, 2026.
Portage Biotech Inc

NASDAQ:PRTG

PRTG Rankings

PRTG Latest News

PRTG Latest SEC Filings

PRTG Stock Data

15.52M
898.55k
60.57%
4.17%
1.59%
Biotechnology
Healthcare
Link
British Virgin Islands
Tortola